Eukaryotic initiation factor 3a promotes the development of diffuse large B-cell lymphoma through regulating cell proliferation

Eukaryotic initiation factor 3a promotes the development of diffuse large B-cell lymphoma through regulating cell proliferation

Abstract Background One-third of diffuse large B-cell lymphoma (DLBCL) patients suffer relapse after standard treatment. Eukaryotic initiation factor 3a (eIF3a) is a key player in the initial stage of translation, which has been widely reported to be correlated with tumorigenesis and therapeutic res...

Full description

Bibliographic Details
Main Authors: Hongkun Sun, Juanjuan Shang, Xiao Liu, Shuai Ren, Shunfeng Hu, Xin Wang
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Cancer
Subjects:
Diffuse large B-cell lymphoma
eIF3a
Cell proliferation
Cell apoptosis
Tumor immune
Chemosensitivity
Online Access:https://doi.org/10.1186/s12885-024-12166-0

Internet

https://doi.org/10.1186/s12885-024-12166-0

Similar Items